Hydroxychloroquine causes viral load reduction in Covid-19 patients
covidtrial.io
covidtrial.io
> just spent a nightmaremorning trying to get my Lupus meds. [after this hydroxychloroquine/covid-19 announcement], no pharmacy has any!
> I spoke directly to the pharmacist. she said that she has no control. this wil be first come first serve, she cannot give preferential treatment even though I have been diagnosed for 33 years and buying this med from her for a long time.
> she has reordered. shes gets many requests an hour today for MY lupus medication. im on a list
There are also several publications under review at the NIH. Glad to see the US Gov. stepping up to the plate so fast on the subject.
...
> Hydroxychloroquine and chloroquine have been recommended by Chinese and South Korean health authorities for the treatment COVID-19.[31] [32] In vitro studies have demonstrated that hydroxychloroquine is more potent than chloroquine against SARS-CoV-2 with a more tolerable safety profile.[33]
> On 16 March 2020, advisor to the French Government on COVID-19, Professor Didier Raoult, announced that a non-randomized unblinded trial[34] involving 24 patients from the south east of France supported the claim that hydroxychloroquine was an effective treatment for COVID-19.[35] The trial is yet to be peer-reviewed.[34] An amount of 600 mg of hydroxychloroquine (brand name Plaquenil) was administered to these patients every day for 10 days. They reported "a significant decrease in viral load".[34] The drug appeared to be responsible for a "rapid and effective speeding up of their healing process, and a sharp decrease in the amount of time they remained contagious".[36] 70% of patients were "considered cured", compared with 12.5% of those who did not receive hydroxychloroquine and azithromycin combination.[34] The antibiotic azithromycin - which is known to be effective against secondary infections from bacterial lung disease - led to even better outcomes. Professor Raoult said the results showed there was "a spectacular reduction in the number of positive cases" with the combination therapy. At 6 days, among patients given combination therapy, the percentage of cases still carrying SARS-CoV-2 was no more than 5%.[37][38]
> On March 17 after testing in several hospitals around Italy the Italian Pharmaceutical Agency has included hydroxychloroquine in the list of drugs with positive preliminary results for treatment of coronavirus disease 2019.[39]
----
What is strange is that azithromycin - leads to better outcomes. It is used for bacterial infections but Covid is a virus. How can this be?
And it's usually not through the bacterial co-infections route unless you find the same effect with all broad spectrum anti-biotics.
The flu doesn’t last as long, but it brings fluid to the lungs. Protecting from infection is huge.
I am not familiar with the observations around type-O blood, but I have been following the discussions on ACE2 and ACE/ACE2 inhibitors (blood pressure meds) which is interesting. The jury is still out on that one, but the theory for ARB's is forcing a binding that blocks nCoV from attaching to the receptor. [4]
[1] - https://examine.com/supplements/quercetin/
[2] - https://www.ncbi.nlm.nih.gov/pubmed/25050823
[3] - https://www.youtube.com/watch?v=vE4_LsftNKM Chloroquin, Quecertin 6 mins in
[0]: https://www.jqknews.com/news/388543-The_novel_coronavirus_pn...
In the malaria parasite, it kills the parasite by hitting up the lysosome (or something intracellular at least - interaction with a protein, can't remember details).
In humans, things get a little bit more fuzzy. It accumulates in lysosomes, and then how it stops Coronaviruses or is effective in lupus treatment isn't very clear. I've seen arguments that it changes pH, or the caspases can't work any more, but that doesn't explain very much.
My bet is that it's screwing with the organisation of the secretory system, which means that virus can't get out properly (maybe budding is broken).
The ABO blood system link is something else altogether, but probably hints towards other functions of blood type in regulating something other than self/other recognition (although virus itself may carry ABO epitope).
[citation appreciated]
Type A: 1.20:1 Type O: 0.67:1
Also the most recent french study is here: https://drive.google.com/file/d/186Bel9RqfsmEx55FDum4xY_IlWS...
https://med.umn.edu/news-events/covid-19-clinical-trial-laun...
I just hope they don't wait "weeks" if they see in 10 days significant results. They can wait weeks for the formal, 100 page study, but hope we see some tweets saying go/no go in 10 days after rolling this out.
Trump also said yesterday I believe he ordered FDA to fast track both versions plus another antiviral remdesivir that is also showing effects.
If the CDC believes that destroying the economy to stop this disease is worth it, then I can't doubt that the FDA would agree that deploying this medication immediately is worth the risk.
- I know one must get tested for G6PD deficiency or it may lead to a hemolytic crisis. But I'm unsure how probable one is to have it or how long until this potential problem arises.
- I heard this drug can cause heart attacks in some people, Can this be predicted by a test? Some users on r/covid19 were advising against taking it without doctor supervision in a hospital for this reason but didn't explain nor gave statistics, as usual. The problem was related to prolonged qt intervals
I.e., perhaps they need not even take this medication?
We sometimes use weakened live viruses as vaccines. For example, we did it for polio.
Hydroxychloroquine weakens the virus. No, it isn't genetically weakened, but that doesn't make a difference. Start the person on hydroxychloroquine, then give them the virus.
https://www.reddit.com/r/COVID19/comments/fjj8yb/chinese_gui...